Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

Clinical trial NCT02862275 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02862275
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Metastatic Malignant Solid Neoplasm Unresectable Malignant Solid Neoplasm

Start date: 2017-05-24
Primary completion: 2026-11-21
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.